Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,294 | -16,092 | -8,337 | -33,316 | -25,098 |
| Depreciation Amortization | 1,589 | 1,037 | 234 | 842 | 611 |
| Accounts receivable | -1,590 | -1,373 | -956 | 1,111 | 697 |
| Accounts payable and accrued liabilities | -3,379 | -224 | 206 | 5,829 | 5,174 |
| Other Working Capital | -4,140 | -1,073 | 2,883 | 5,191 | 4,425 |
| Other Operating Activity | 10,985 | 5,656 | 2,922 | -565 | -1,581 |
| Operating Cash Flow | $-19,829 | $-12,069 | $-3,048 | $-20,908 | $-15,772 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -463 | -308 | -239 | -1,321 | -1,311 |
| Purchase Sale Intangibles | -10 | -10 | -10 | -131 | -45 |
| Other Investing Activity | -58 | -57 | -57 | -454 | -45 |
| Investing Cash Flow | $-521 | $-365 | $-296 | $-1,775 | $-1,356 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,000 | 10,000 | N/A | N/A | N/A |
| Common Stock Issued | 7,379 | 271 | 107 | 529 | 520 |
| Common Stock Repurchased | N/A | N/A | N/A | -404 | -404 |
| Other Financing Activity | -766 | -693 | -52 | -215 | -163 |
| Financing Cash Flow | $16,613 | $9,578 | $55 | $-90 | $-47 |
| Beginning Cash Position | 22,616 | 22,616 | 22,616 | 45,389 | 45,389 |
| End Cash Position | 18,879 | 19,760 | 19,327 | 22,616 | 28,214 |
| Net Cash Flow | $-3,737 | $-2,856 | $-3,289 | $-22,773 | $-17,175 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,829 | -12,069 | -3,048 | -20,908 | -15,772 |
| Capital Expenditure | -463 | -308 | -239 | -1,321 | -1,311 |
| Free Cash Flow | -20,292 | -12,377 | -3,287 | -22,229 | -17,083 |